In the Hur et al. study, circulating levels of adiponectin, which has anti-diabetic properties was reduced in T2D compared to nonincident diabetic mellitus subjects, suggesting irisin may be associated with incident T2D independently of metabolic risk factors such as BMI and omeostatic model assessment for insulin resistance [13]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.